삼성서울병원

Ko En

Ahn, Yong Chan M.D

TITLE
Professor
Department of Radiation Oncology
Samsung Medical Center
Sungkyunkwan University School of Medicine
Treament Schedule 06 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 07 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   1992. 08 ~ 1993. 06: Research Fellow, Roswell Park Cancer Institute, USA
1993. 07 ~ 1994. 04: Clinical Fellow, British Columbia Cancer Agency, Canada
Residency   1989. 05 ~ 1992. 02: Seoul National University Hospital
Internship   1984. 03 ~ 1985. 02: Seoul National University Hospital

Other Education

2003. 08 ~ 2003. 10: Visiting Professor, Hokkaido University Medical School

Clinical & Research Interests

Head/Neck Oncology
Thoracic Oncology (Lung cancer, Esophageal cancer, Mediastinal tumor)
Stomach Cancer
Lymphoma
Sarcoma

Participation in Academic Societies
and Research

Domestic:
2001. 01 ~ Director, The Korean Lung Cancer Study Group
2004. 07 ~ Director, Korean Cancer Association
2004. 10 ~ 2007. 09: Director of General Affairs and Treasury, Korean Society for Therapeutic Radiology and Oncology
2007. 10 ~ Director of Board Qualifying Examination, Korean Society for Therapeutic Radiology and Oncology
2008. 10 ~ Vice-Editor-in-Chief, Korean Cancer Association
2008. 11 ~ Director of Public Relation, Korean Society for Head & Neck Oncology

International Membership:
American Society for Therapeutic Radiology and Oncology (ASTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)

Selected Publications

  • INT J RADIAT ONCOL 2019 10.1016/j.ijrobp.2019.06.2540 International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma Lee1, AW; Ng, WT; Pan, JJ; Chiang, CL; Poh, SS; Choi, HC; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Sanguineti, G; Soong, YL; Tao, YA; Yom, SS; Wee, JT
    View PubMed
  • Journal of thoracic disease 2019 10.21037/jtd.2019.10.18 Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between "reality" and "illusion"? Nam1, H; Noh, JM; Park, SG; Ahn, YC
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759 Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY
    View PubMed
  • J RADIAT RES 2019 10.1093/jrr/rrz040 Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score Kim1, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D
    View PubMed
  • CANCER SCI 2019 10.1111/cas.14115 Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer Park1, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S
    View PubMed